The Effects of SARS-CoV-2 Infection on Female Fertility: A Review of the Literature.

COVID-19 SARS-CoV-2 embryos endometrium female reproductive system follicular fluid in vitro fertilization menstrual cycle oocytes ovarian reserve

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
16 Jan 2022
Historique:
received: 17 12 2021
revised: 10 01 2022
accepted: 14 01 2022
entrez: 21 1 2022
pubmed: 22 1 2022
medline: 29 1 2022
Statut: epublish

Résumé

As the coronavirus pandemic is far from ending, more questions regarding the female reproductive system, particularly fertility issues, arise. The purpose of this paper is to bring light upon the possible link between COVID-19 and women's reproductive health. This review emphasizes the effect of SARS-CoV-2 on the hormones, endometrium and menstrual cycle, ovarian reserve, follicular fluid, oocytes, and embryos. The results showed that endometrial samples did not express SARS-CoV-2 RNA. Regarding the menstrual cycle, there is a large range of alterations, but they were all reversible within the following months. The ovarian reserve was not significantly affected in patients recovering from both mild and severe infection in most cases, except one, where the levels of AMH were significantly lower and basal follicle-stimulating hormone (FSH) levels were increased. All COVID-19 recovered patients had positive levels of SARS-CoV-2 IgG in the follicular fluid. The amount of retrieved and mature oocytes and the fertilization rate were unharmed in three studies, except for one study, where the quantity of retrieved and mature oocytes was reduced in patients with higher levels of SARS-CoV-2 antibodies. The numbers of blastocysts, top-quality embryos, and euploid embryos were affected in most of the studies reviewed.

Identifiants

pubmed: 35055804
pii: ijerph19020984
doi: 10.3390/ijerph19020984
pmc: PMC8775865
pii:
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

PLoS One. 2021 Oct 20;16(10):e0258314
pubmed: 34669726
Gend Med. 2005 Mar;2(1):41-56
pubmed: 16115597
F S Sci. 2021 Feb;2(1):33-42
pubmed: 33521687
Reproduction. 2002 Jun;123(6):807-18
pubmed: 12052235
J Assist Reprod Genet. 2015 Mar;32(3):417-27
pubmed: 25595538
Virol Sin. 2020 Jun;35(3):337-339
pubmed: 32198713
Fertil Steril. 2020 Sep;114(3):484-485
pubmed: 32674808
Medicina (Kaunas). 2020 Jun 22;56(6):
pubmed: 32580461
Stem Cell Rev Rep. 2021 Feb;17(1):278-284
pubmed: 33403489
Reprod Biomed Online. 2021 Dec;43(6):1117-1121
pubmed: 34711516
Int J Prev Med. 2020 Jul 09;11:97
pubmed: 33042494
Gynecol Endocrinol. 2021 Oct;37(10):895-897
pubmed: 33974475
J Obstet Gynaecol Res. 2021 Sep;47(9):3241-3249
pubmed: 34137123
Fertil Steril. 2020 Aug;114(2):223-232
pubmed: 32641214
Science. 2015 Jan 23;347(6220):1260419
pubmed: 25613900
J Mol Cell Biol. 2021 Dec 30;13(10):695-704
pubmed: 34003284
Int J Epidemiol. 2021 Dec 02;:
pubmed: 34865021
Fertil Steril. 2007 Oct;88(4 Suppl):1101-7
pubmed: 17544416
J Chronic Dis. 1961 Oct;14:396-407
pubmed: 13887810
BMJ. 2021 Aug 25;374:n2113
pubmed: 34433543
J Clin Endocrinol Metab. 2005 Nov;90(11):6141-8
pubmed: 16118339
Biol Reprod. 1996 Feb;54(2):436-45
pubmed: 8788197
Theriogenology. 2006 Dec;66(9):2068-76
pubmed: 16889824
Protein J. 2020 Dec;39(6):644-656
pubmed: 33106987
Reprod Biomed Online. 2021 Oct;43(4):769
pubmed: 34489182
J Biomed Sci. 2016 Mar 29;23:36
pubmed: 27026099
Sci Immunol. 2020 May 13;5(47):
pubmed: 32404436
Arch Med Res. 2020 Jul;51(5):384-387
pubmed: 32402576
Am J Obstet Gynecol. 2020 Aug;223(2):275-278
pubmed: 32405074
Int J Gynaecol Obstet. 2020 Jul;150(1):98-102
pubmed: 32392400
Fertil Steril. 2011 Jan;95(1):176-81
pubmed: 20674894
Annu Rev Physiol. 1997;59:349-63
pubmed: 9074768
Reproduction. 2007 Nov;134(5):713-9
pubmed: 17965262
J Clin Invest. 2020 Sep 1;130(9):4947-4953
pubmed: 32573498
Reprod Biomed Online. 2016 Dec;33(6):668-683
pubmed: 27742259
Reprod Biol. 2005 Jul;5(2):111-36
pubmed: 16100562
Urology. 2020 Aug;142:42
pubmed: 32343996
J Womens Health (Larchmt). 2022 Jan;31(1):84-90
pubmed: 34582731
Hum Reprod. 1997 Dec;12(12):2804-9
pubmed: 9455857
Hum Reprod. 1999 Mar;14(3):628-35
pubmed: 10221687
Genomics. 2021 Nov;113(6):3449-3460
pubmed: 34418496
Proc Natl Acad Sci U S A. 2020 Jun 30;117(26):14857-14863
pubmed: 32527856
Fertil Steril. 2020 Jul;114(1):33-43
pubmed: 32622411
Biochim Biophys Acta Mol Basis Dis. 2022 Jan 1;1868(1):166295
pubmed: 34718118
Reprod Biol Endocrinol. 2009 May 04;7:40
pubmed: 19413899
Hum Reprod. 2021 Aug 18;36(9):2506-2513
pubmed: 34364311
Hum Reprod. 2021 Jan 25;36(2):390-394
pubmed: 32998162
Reprod Sci. 2021 Aug;28(8):2144-2146
pubmed: 33616884
Reprod Sci. 2009 Mar;16(3):247-56
pubmed: 19164480
J Assist Reprod Genet. 2013 Sep;30(9):1231-8
pubmed: 23888310
Am J Obstet Gynecol. 2021 Oct 21;:
pubmed: 34688597
Front Sports Act Living. 2021 Feb 16;3:606799
pubmed: 33665612
Front Med (Lausanne). 2021 Mar 19;8:635255
pubmed: 33816526
EClinicalMedicine. 2021 Aug;38:101013
pubmed: 34250457
Intern Emerg Med. 2020 Nov;15(8):1583-1584
pubmed: 32666177
Reprod Biol Endocrinol. 2005 Jul 14;3:28
pubmed: 16018814
Exp Physiol. 2011 Mar;96(3):287-94
pubmed: 21148624
Crit Care. 2020 Jul 13;24(1):422
pubmed: 32660650
Front Endocrinol (Lausanne). 2021 Mar 22;12:642755
pubmed: 33841334
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Am J Obstet Gynecol. 2021 Sep 20;:
pubmed: 34555320
J Obstet Gynaecol. 2021 Nov;41(8):1257-1261
pubmed: 33955327
Natl Sci Rev. 2020 Sep;7(9):1414-1418
pubmed: 34192086
Int J Clin Exp Pathol. 2015 Aug 01;8(8):8948-57
pubmed: 26464636
Reprod Biomed Online. 2021 Jan;42(1):260-267
pubmed: 33288478
J Gynecol Obstet Hum Reprod. 2022 Jan;51(1):102251
pubmed: 34638007

Auteurs

Andreea Carp-Veliscu (A)

Department of Obstetrics and Gynecology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Panait Sarbu Clinical Hospital of Obstetrics and Gynaecology, 060251 Bucharest, Romania.

Claudia Mehedintu (C)

Department of Obstetrics and Gynecology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Nicolae Malaxa Clinical Hospital Bucharest, 022441 Bucharest, Romania.

Francesca Frincu (F)

Department of Obstetrics and Gynecology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Nicolae Malaxa Clinical Hospital Bucharest, 022441 Bucharest, Romania.

Elvira Bratila (E)

Department of Obstetrics and Gynecology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Panait Sarbu Clinical Hospital of Obstetrics and Gynaecology, 060251 Bucharest, Romania.

Simona Rasu (S)

Panait Sarbu Clinical Hospital of Obstetrics and Gynaecology, 060251 Bucharest, Romania.

Ioana Iordache (I)

Department of Obstetrics and Gynecology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Panait Sarbu Clinical Hospital of Obstetrics and Gynaecology, 060251 Bucharest, Romania.

Alina Bordea (A)

Department of Obstetrics and Gynecology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Panait Sarbu Clinical Hospital of Obstetrics and Gynaecology, 060251 Bucharest, Romania.

Mihaela Braga (M)

Panait Sarbu Clinical Hospital of Obstetrics and Gynaecology, 060251 Bucharest, Romania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH